Evidence map›Paper›PMID 33437098›Full record

ArticleMonatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde2021

[Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic].

Kirsten Mönkemöller, Clemens Kamrath, Johanna Hammersen, Torben Biester, Katharina Warncke, Angeliki Pappa, Katharina Fink, Klemens Raile, Tilman R Rohrer, Reinhard W Holl and 1 more

Open access · bronzeAbstract readEnglish Abstract
In one paragraph

Article in Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Kirsten MönkemöllerKlinik für Kinder und Jugendmedizin, Kinderkrankenhaus Amsterdamer Straße, Amsterdamer Straße 59, 50735 Köln, Deutschland.
Clemens KamrathAbteilung für pädiatrische Diabetologie und Endokrinologie, Allgemeine Pädiatrie und Neonatologie, Universitätsklinikum, Justus Liebig Universität Gießen, Gießen, Deutschland.
Johanna HammersenAbteilung für Kinder und Jugendmedizin, Universitätsklinikum Erlangen, Erlangen, Deutschland.
Torben BiesterDiabeteszentrum für Kinder und Jugendliche, Kinder- und Jugendkrankenhaus auf der Bult, Hannover, Deutschland.
Katharina WarnckeKlinik und Poliklinik für Kinder- und Jugendmedizin, Kinderklinik München Schwabing, Fakultät für Medizin, Technische Universität München, München, Deutschland.
Angeliki PappaKlinik für Kinder- und Jugendmedizin, Universitätsklinikum RWTH Aachen, Aachen, Deutschland.
Katharina FinkInstitut für Epidemiologie und medizinische Biometrie, ZIBMT, Universität Ulm, Ulm, Deutschland.
Klemens RaileAbteilung für pädiatrische Endokrinologie und Diabetologie, Charité, Universitätsmedizin Berlin, Berlin, Deutschland.
Tilman R RohrerAbteilung für Pädiatrie, Universitätsklinikum des Saarlandes, Homburg/Saar, Deutschland.
Reinhard W HollInstitut für Epidemiologie und medizinische Biometrie, ZIBMT, Universität Ulm, Ulm, Deutschland.
DPV Initiative
Universität Ulm · DEHelmholtz Zentrum München · DEJustus-Liebig-Universität Gießen · DEUniversitätsklinikum des Saarlandes · DEAltonaer Kinderkrankenhaus · DEKinderkrankenhaus auf der Bult · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic ketoacidosis (DKA) is a life-threatening emergency in children and adolescents with manifestation of type 1 diabetes mellitus (DM1) and often associated with delayed diagnosis or previous diagnostic errors. During the coronavirus disease 2019 (COVID-19) lockdown period in Germany, less patients presented at emergency departments and private practices

objectiveThe aim of this study was to investigate the DKA risk in children and adolescents with DM1 manifestation during the COVID-19 lockdown and associated risk factors. MATERIAL AND

methodsThe frequency of DKA at DM1 onset in patients <18 years between 13 March and 13 May 2020 in pediatric diabetes centers was analyzed. The centers also documented their assessment, if the presentation was delayed or the diagnosis was not made on the first medical consultation. In order to analyze the influence of the risk factors on the frequency of DKA, the data from 2020 were compared with the same periods in 2018 and 2019 using multivariable linear and logistic regression.

resultsThe data of 532 patients from 216 diabetes centers showed that the risk for DKA increased by 84.7% and the risk for severe DKA increased by 45.3% compared to the years 2018/2019. Children <6 years had the highest risk with an 141.6% increase for DKA and 97.0% for severe DKA compared to the previous years. Migration background was a risk factor independent of COVID-19. Of the patients 31% had either a delayed presentation or a missed diagnosis.

conclusionDuring the COVID-19 lockdown the frequency of DKA and severe DKA at DM1 onset was significantly increased for children and adolescents in Germany. Age <6 years, migration background and delayed diagnosis were the main risk factors.

Indexed as

Children < 6 yearsCOVID-19 lockdownDelayed presentationMigration backgroundMissed diagnosis

Identifiers

PMID33437098
PMCPMC7791536
OpenAlexW3119066397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.